Podcast appearances and mentions of Jim Mellon

Therapeutics, vaccines, Regeneron, will therapeutics replace vaccines?, the biotechnology industry, genetic engineering, Stanford, University of California at San Francisco (UCSF), the roll of the Bay area in biotech, advances in gene editing during the 1990s, mRNA and its links to therapeutics, Jesse Gelsinger, Bush II and bans on research, lipid nanoparticles (LNPs), the advent of synthetic biology, cell therapy, stem cells, embryonic stem cell controversy, CRISPR, CRISPR CaS9, Jennifer Dounda, Emmanuelle Cherpentier, Feng Zhang, Broad Institute, UC Berkeley, Intellia Therapeutics, CRISPR Therapeutics, Operation Warp Speed, Editas Medicine, Innovative Genomics Institute (IGI), Covid vaccines, why the Covid vaccines are more like a therapeutic, AI biotech, AlphaFold2, tech money piles into biotech post pandemic, Arc Institute, Vitalik Buterin, Big Pharma and its lack of involvement in therapeutics, Big Tech's entry into defense and healthcare, Peter Thiel, Thiel as the catalyst for modern therapeutic research, life-extension, Thiel's extensive investment in therapeutics and biotech, Jason Camm, Jim Mellon, Brexit, Thiel's lack of investment in CRISPRResourcesTrump on "miracle drugs":https://www.yahoo.com/news/article/trump-coronavirus-twitter-video-234914108.html?guccounter=1On the links between therapeutics and the Covid vaccineshttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02444-3/fulltexthttps://pmc.ncbi.nlm.nih.gov/articles/PMC12179814/AI Biotechhttps://whatisbiotechnology.org/index.php/science/summary/aiBig Tech and AI biotechhttps://www.forbes.com/sites/richardnieva/2024/03/13/why-nvidia-google-and-microsoft-are-betting-billions-on-biotechs-ai-future/How funding for biotech has unfolded since the 2010shttps://www.fiercebiotech.com/biotech/how-healthy-exchange-ideas-rfk-jr-kicked-fdas-gene-therapy-pushThiel's Links to Biotechhttps://www.technologyreview.com/2015/03/16/168909/a-contrarian-in-biotech/https://sociallifemagazine.com/celebrities/bezos-thiel-longevity-investments/https://www.inc.com/jeff-bercovici/emerald-therapeutics-peter-thiel.htmlhttps://www.fiercebiotech.com/biotech/thiel-s-breakout-labs-fuels-four-new-life-science-companieshttps://alloytx.com/42-million-series-d-financing/https://www.wholesaleinvestor.com/epiaxis-therapeutics-peter-thiel-backed-peptilogics-enter-strategic-partnership/https://www.businessinsider.com/peter-thiel-funded-de-extinction-animal-resurrection-woolly-mammoth-2017-6https://www.sfgate.com/tech/article/synthego-after-raising-forced-bankrupcty-20331773.phpJason Camm's biohttps://www.berentx.com/companyMusic by: Keith Allen Dennishttps://keithallendennis.bandcamp.com/ Hosted on Acast. See acast.com/privacy for more information.

Episode Summary:  Five years ago, billionaire investor Jim Mellon came on Business For Good and laid out his thesis that cultivated meat and precision fermentation would transform the food system. Since then, venture capital has fled the space, plant-based stocks have cratered, and many startups have gone under. So why is Jim putting even more money in? In this episode, Paul Shapiro reconnects with Jim Mellon, Author of Moo's Law and Chairman of Agronomics, to find out what has changed and what hasn't. Jim reveals that his portfolio company, Clean Food Group, is producing precision fermentation-based palm oil, olive oil, and cocoa butter at a factory near Liverpool that is already sold out to buyers, including Mondelēz. He shares how media costs for cultivated meat have dropped from nearly $1,000 per liter to under three cents, and why he expects the company to go public later this year in what could be the first IPO of a precision fermentation company. The conversation also covers why the Middle East may become the next major hub for alternative protein infrastructure, how robotics could improve agricultural yields and reduce food waste, and what Jim plans to change in the updated edition of Moo's Law. He also explains why, despite personal wealth, no single investor can fund the scale of infrastructure this industry requires. Things You Will Learn: How precision fermentation-based oils are already reaching price parity with conventional palm oil, olive oil, and cocoa butter. Why cultivated meat media costs have dropped from roughly $1,000 per liter to under three cents in just a few years. Why the Middle East could become the next major hub for alternative protein manufacturing. What Jim Mellon plans to change in the updated edition of Moo's Law. How robotics and AI could reduce crop waste and improve agricultural yields globally. Tools & Frameworks Covered: Moo's Law: The idea that the cost of producing cultivated animal products will decline on a curve similar to Moore's Law in computing, driven by advances in media formulation, facility design, and scale. Precision Fermentation for Commodity Oils: Using microbial fermentation to produce bio-identical palm oil, cocoa butter, and olive oil at competitive prices with greater supply consistency and without deforestation. Infrastructure-First Scaling: Building dedicated production facilities and securing offtake agreements before going to market, reducing capital carry costs, and proving commercial viability to attract institutional investment. #BusinessForGood #FutureOfFood #AlternativeProtein #SustainableBusiness

Merryn Somerset Webb sits down with John Stepek, Jim Mellon, billionaire investor and Chairman of The Burnbrae Group, and Blue Whale manager Stephen Yiu. The panel was part of the Master Investor Show, the UK’s largest gathering for private investors. This conversation was recorded on Saturday, April 25, 2026. See omnystudio.com/listener for privacy information.

We're revisiting one of our most fascinating conversations on The Jess Larsen Show on Innovation & Leadership. In this throwback episode, Jess sits down with billionaire investor, entrepreneur, and futurist Jim Mellon to explore the ideas shaping the future of business, technology, and human life itself. From his early days witnessing the rise of Silicon Valley alongside figures like Bill Gates and Steve Jobs, to building a global investment career across emerging markets, Jim shares the mindset that has allowed him to navigate decades of constant change. He reflects on missed opportunities, the importance of curiosity, and why adaptability is no longer optional in today's world. The conversation goes far beyond traditional investing. Jim dives into his work in longevity science, the future of food production, and the transformative potential of quantum computing and fusion energy. He also shares candid advice on how to think about risk, avoid hype cycles, and identify real opportunities in emerging industries. This episode is a deep look into how long-term thinkers approach innovation, uncertainty, and the future. If you're interested in where the world is heading and how to position yourself ahead of it, this is a conversation worth revisiting. Learn more about your ad choices. Visit megaphone.fm/adchoices

In a recent conversation with renowned investor Jim Mellon, Zak Mir delved deep into the state of the financial markets as we reach the midpoint of 2025. Jim, known as one of the UK's largest and most astute investors, shared his candid views on the evolving global economic landscape, highlighting key opportunities and risks for investors today.  The Market Environment in 2025: A Year of Surprises and Strategic Shifts So far this year, the markets have experienced significant turbulence, exemplified by what Jim refers to as the “tariff dip” — a sharp market decline triggered by renewed tariff tensions and geopolitical uncertainties. However, rather than retreating, Jim and his team saw this as a buying opportunity, particularly focusing on regions outside the United States. While many investors were fixated on the US market, Jim emphasized that his portfolio strategy deliberately concentrated on Europe, the UK, and Asia, with a selective approach to US stocks. This regional focus has paid off well, as these markets have demonstrated resilience amid global headwinds. Concerns Over the US Fiscal Situation One of the major themes Jim highlighted was the precarious fiscal position of the United States. He pointed out that the US economy is taxed at approximately 30%, but government spending sits at 38%, creating a widening fiscal gap that poses serious risks. This imbalance, he warned, could trigger severe disruptions in the US bond market and a significant depreciation of the US dollar over the next year. “The US taxes its economy at 30% and spends 38%, and that gap is widening. That opens the possibility of very big ructions in the bond market and big falls in the US dollar, which I fully expect to happen over the next year or so.” Given these risks, Jim advises investors to generally avoid the US market, except for a few select stocks. Instead, he advocates for increased exposure to the UK, Europe, Asia, and emerging markets, which he believes will be the primary beneficiaries of the challenges facing the US economy. Why the UK and Europe Remain Attractive Despite Political Uncertainty Read More https://www.share-talk.com/interview-with-jim-mellon-insights-on-the-2025-market-landscape-and-investment-strategies/

In this edition of the Money Makers Investment Trusts Podcast, Jonathan Davis, editor of the Investment Trusts Handbook and winner of the 2024 AIC Best Broadcast Journalist Award, is joined by Jim Mellon, businessman, investor, and entrepreneur. This discussion was recorded on Monday 09 June 2025. *** Out now: The 2025 Investment Trusts Handbook *** The Investment Trusts Handbook is an independent educational publication designed to provide investors with a handy annual reference book that summarises all you need to know about investment trusts. Now in its eighth year, the Handbook is a high-quality, full-colour hardback of more than 340 pages, the largest yet, with reviews of the past year, extensive interviews and commentary, plus nearly 80 pages of “how to” information and performance data. Available to order from Harriman House (https://harriman-house.com/ithb2025) or Amazon. There is also a free e-book version you can read on a PC, tablet or smartphone, plus an audiobook version. *** Section Timestamps: 0:00:24 - Introduction 0:00:49 - The Trump administration and volatility 0:07:36 - Reacting to a potential crisis 0:10:51 - The investment approach 0:16:31 - A short break 0:17:37 - Luck or skill in investment success 0:20:52 - Looking at Germany 0:24:46 - Reinforcing the UK stock market 0:26:36 - Other activities 0:31:01 - Close If you enjoy the weekly podcast, you may also find value in joining The Money Makers Circle. This is a membership scheme that offers listeners to the podcast an opportunity, in return for a modest monthly or annual subscription, to receive additional premium content, including interviews, performance data, links to third party research, market/portfolio reviews and regular comments from the editor. A subscription costs £12 a month or £120 for one year. This week, as well as the usual features, the Circle features a profile of Pershing Square Holdings (PSH). Future profiles include VietNam Holdings (VNH) and Fidelity Emerging Markets (FEML). Our new expanded weekly subscriber email includes a comprehensive summary of all the latest news plus the week's biggest share price, NAV and discount movements. Subscribe and you will never miss any important developments from the sector. For more information please visit money-makers.co/membership-join. Membership helps to cover the cost of producing the weekly investment trust podcast, which will continue to be free for the foreseeable future. We are very grateful for your continued support and the enthusiastic response to our more than 280 podcasts since launch. You can find more information, including relevant disclosures, at www.money-makers.co. Please note that this podcast is provided for educational purposes only and nothing you hear should be considered as investment advice. Our podcasts are also available on the Association of Investment Companies website, www.theaic.co.uk. Produced by Ben Gamblin - www.bgprofessional.co.uk

Global Markets: What's Next? A Deep Dive into Macroeconomics, Markets & Future-Proof Investment Ideas. Join Wilfred Frost, renowned News Anchor at Sky News, in conversation with legendary investor and entrepreneur Jim Mellon at the Master Investor Show 2025. In this exclusive interview, Jim shares his sharp insights on the state of the US economy, upcoming political and market shifts, and how these developments are set to impact investors globally. They also explore emerging opportunities across asset classes and regions—from biotech to AI to alternative assets—offering actionable ideas and foresight into what the next big investment themes could be.

If you follow the world of cultivated meat, you probably know that a few companies have gotten historic regulatory approval and have sold some limited quantities of product both in the US and Singapore. But earlier this year, Meatly—a company founded only in 2021 and with just a few million British pounds in their pocket—succeeded in getting regulatory approval to start selling its cultivated chicken meat…in pet food. This was the first-ever European approval for a cultivated meat product, and the first-ever approval for such a product in the pet food space. And as someone with a dog who sadly makes his distaste for plant-based dog food very clear, I can assure you that I'm eager to see if my dog Eddie will enjoy Meatly's debut product.  In this episode, I talk with Meatly CEO Owen Ensor about his journey from starting the company to now. We discuss the scale he's at, the cost structure of his product, the inclusion rates in pet food he anticipates, what stores he plans to sell in at first, how he'll fund the company, when he thinks cultivated meat may make a dent in total meat demand, and much more.  It's a riveting conversation with someone making headlines across the alt-meat world. Will pet food be the gateway for cultivated meat's market entrance? You be the judge. Discussed in this episode Owen became vegan after watching Cowspiracy. Owen's chart showing the timeline to regulatory approval for various cultivated meat companies. Paul's essay on pet food's contribution to total meat demand. Bond is another company growing chicken protein for the pet market. You can see Paul's dog Eddie enjoying it here. Our past episodes with Jim Mellon from Agronomics and Mark Post from Mosa Meat. Owen recommends reading Good to Great. More about Owen Ensor Owen is the Founding CEO of Meatly. Since establishing Meatly in 2021, with only £3.5m in funding, it has become the first company in Europe to get regulatory approval for cultivated meat, developed industry-leading technical processes, and created the world's first cultivated pet food products. Before establishing Meatly, Owen started his career at the Management Consultancy company Bain and scaled one of the world's first insect protein facilities.

Interview with Mark Child, CEO of Condor Gold PLCOur previous interview: https://www.cruxinvestor.com/posts/condor-gold-cnr-primed-for-a-take-over-2557Recording date: 16th September 2024Condor Gold PLC, a London and Toronto-listed mining company, presents an intriguing investment opportunity in the gold sector with its La India project in Nicaragua. The company has positioned itself as a potential acquisition target, offering investors exposure to a high-grade, fully-permitted gold asset in a rising precious metals market.The La India project boasts a substantial 2.4 million ounce gold resource, with an impressive grade of 4 grams per tonne. Half of this resource is open pit, while the other half is underground. Condor Gold has completed a bankable feasibility study on the main pit, which represents about 40% of the total ounces.CEO Mark Child outlines three production scenarios:Reserve Case: 82,000 ounces of gold per annumOpen Pit Scenario: 120,000 ounces per annum (including feeder pits)Combined Open Pit and Underground: 150,000 ounces per annumA key strength of the project is its "shovel ready" status. Condor Gold has secured all necessary permits for construction and operation, as well as acquired all required surface rights, investing $45 million in land acquisition across 55 plots. This comprehensive approach significantly de-risks the project for potential buyers.The economic potential of La India is substantial, particularly in the current gold price environment. At $1,600/oz gold, the project demonstrates robust economics with a 23% IRR for the reserve pit. At $2,000/oz gold, EBITDA more than doubles to approximately $750 million for the reserve pit alone. The high-grade nature of the deposit provides significant leverage to gold prices, with minimal change in operating costs as prices rise.One of the most attractive aspects of the La India project is its relatively modest capital expenditure requirement of $105 million. This low initial capital outlay broadens the pool of potential acquirers, as it's within reach for mid-tier producers and even some junior miners.However, investors should be aware of the jurisdictional risks associated with Nicaragua. While the government is supportive of mining and there are other operating mines in the country, Nicaragua faces international scrutiny due to concerns about its democratic processes, resulting in U.S. sanctions on certain individuals and entities. These sanctions, while a consideration, do not directly impact mining operations.Condor Gold has engaged Hannam & Partners to run a formal sale process, with at least eight companies under confidentiality agreements and more expressing interest. The company's largest shareholder and chairman, Jim Mellon, who owns 26% of the company, is leading the sale negotiations, seeking a valuation that reflects the project's true worth. For investors, the significant disconnect between the company's market valuation (approximately $60 million) and the project's net present value (ranging from $350 million to $900 million) presents a potential opportunity. Any announcement of a transaction could result in a substantial re-rating of the stock.In conclusion, Condor Gold offers a high-risk, high-reward proposition for investors bullish on gold and willing to navigate the complexities of frontier market mining. The company's advanced-stage, high-grade asset, coupled with the ongoing sale process, provides a unique opportunity for potential value realization in the near term. However, investors should carefully consider the jurisdictional risks and uncertainties surrounding the sale process when evaluating this investment opportunity.View Condor Gold's company profile: https://www.cruxinvestor.com/companies/condor-goldSign up for Crux Investor: https://cruxinvestor.com

Has science cracked the code on mass producing realistic meat substitutes? Or are lab-gown alternative proteins an impossible dream? In this week's episode of Cleaning Up, Baroness Bryony Worthington sits down with president of the Good Food Institute, Bruce Friedrich, to explore the future of food. Friedrich details his vision for a more sustainable food system through technologies like plant-based and cultivated meat and outlines the promising progress and significant challenges remaining in scaling these novel proteins. Worthington and Friedrich debate the roles of policy, public opinion, and big agriculture in determining whether alternative proteins can truly transform our food system or remain forever niche.Links and more: The Good Food Institute (https://gfi.org) TEA of cultivated meat. Future projections for different scenarios (https://cedelft.eu/publications/tea-of-cultivated-meat/) A new land dividend: the opportunity of alternative proteins in Europe (https://green-alliance.org.uk/publication/a-new-land-dividend-the-opportunity-of-alternative-proteins-in-europe/) Recipe for a Livable Planet: Achieving Net Zero Emissions in the Agrifood System: (https://openknowledge.worldbank.org/entities/publication/406c71a3-c13f-49cd-8f3f-a071715858fb) UNEP Report on alternative proteins (https://www.unep.org/resources/whats-cooking-assessment-potential-impacts-selected-novel-alternatives-conventional) Episode 136 with Jim Mellon (https://www.youtube.com/watch?v=jqFPic5iqds)

Join Jess Larsen for an enlightening exchange with Jim Mellon, an esteemed investor and author whose expertise spans multiple industries. In this episode, Jim discusses his journey from early travels in Hong Kong to becoming a leading figure in the investment world. Delve into his transition from entrepreneurship to advocacy in longevity and health, where his far-sighted investments are shaping a new paradigm of living and working. Discover the insights that have driven him to write numerous books as he considers dedicating himself fully to authorship. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, Nick talks to Anthony Chow, Co-Founder of Agronomics. Anthony co-founded Argonomics in 2018 alongside author, entrepreneur and investor, Jim Mellon. Agronomics is the leading London listed company in the field of cellular agriculture. Cellular agriculture is the production of agriculture products directly from cell cultures that would have otherwise been derived from traditional agriculture methods. Nick and Anthony discuss cellular agriculture, looking at some of Anthony's key investments and discussing what the sector will look like in the next 5-10 years. Anthony's book choice was Material World: A Substantial Story of Our Past and Future by Ed Conway This content is issued by Zeus Capital Limited (“Zeus”) (Incorporated in England & Wales No. 4417845), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority (“FCA”) for designated investment business, (Reg No. 224621) and is a member firm of the London Stock Exchange. This content is for information purposes only and neither the information contained, nor the opinions expressed within, constitute or are to be construed as an offer or a solicitation of an offer to buy or sell the securities or other instruments mentioned in it. Zeus shall not be liable for any direct or indirect damages, including lost profits arising in any way from the information contained in this material. This material is for the use of intended recipients only.

Jim Mellon is an author, entrepreneur and an investor with interests in a number of sectors. He has substantial real estate holdings in Germany and the Isle of Man, as well as holdings in private and public companies through his private investment company Burnbrae Group. After leaving Oxford, where he studied Philosophy, Politics and Economics, he worked in Asia and the United States in two fund management companies. Mr. Mellon is the co-author of five books, all written with a view to identifying emerging thematic trends leading to investment opportunities.  We had a great chat with Jim and learned about his in-depth and hands on experience within the field of cellular agriculture. --- Support this podcast: https://podcasters.spotify.com/pod/show/futurefoodshow/support

Double feature this week--here is the second day of Merryn's panel "The Butcher, the Brewer, the Baker." Again, it was held at Panmure House--Adam Smith's residence between 1778 and 1790. We taped this panel on August 27, 2023. Guests include: Jim Mellon, Richard Wilson, Paul Johnson and Simon Evans.Sign up to John Stepek's Money Distilled: https://www.bloomberg.com/account/newsletters/uk-wealthSee omnystudio.com/listener for privacy information.

This week's guest on Cleaning Up is entrepreneur, author and philanthropist Jim Mellon. Jim is Executive Director at Agronomics, one of the world's leading investors in cellular agriculture, or lab-grown meat. Bypassing traditional agricultural methods with precision fermentation could have huge implications for CO2 emissions and the climate, and in 2020 Jim wrote Moo's Law as a guide for fellow investors into what he calls the "new agrarian revolution."Jim and Michael discuss the latest developments in cellular agriculture - from pet food to leather goods and restaurant-grade sushi - and how far we are from finding lab-grown products on our supermarket shelves.  Links and Related EpisodesWatch Episode 110 with Lord Adair Turner: https://www.cleaningup.live/ep110-adair-turner-lord-of-the-net-zero-transition/Discover Agronomics and their portfolio companies here: https://agronomics.im/Read more about Moo's Law here: https://mooslawbook.com/Discover Jim's children's book, Juno's Ark, here: https://junosark.com/Jim spoke to Bloomberg's In The City podcast in April about Britain's economic health: https://www.bloomberg.com/news/articles/2023-04-06/podcast-burnbrae-s-jim-mellon-sees-a-bright-future-for-britain-and-the-city?in_source=embedded-checkout-banner#xj4y7vzkg Guest BioJim worked in Asia and the United States at two fund management companies, GT and Thornton, before establishing his own business in 1991. This business continues today, but Jim no longer works as a fund manager and is instead focused on biotech, clean food and property, with other business interests managed by his family office, the Burnbrae Group. Jim has a special interest in health resilience and longevity science, and is the co-founder of Juvenescence, a company investing in the development of therapies for ageing and the diseases of ageing. Jim also co-founded Agronomics Limited in 2011, an investment company focused on opportunities within the nascent industry of environmentally-friendly and cruelty-free modern foods.Jim holds a degree in Politics, Philosophy and Economics from Oriel College, Oxford, where he is an honorary fellow and supports the Mellon Scholarship in Ageing and Cell Senescence. 

The food system is responsible for one third of global emissions and it is estimated that livestock farming alone makes up 15% of global greenhouse gas emissions – that's almost as much as the entire transport sector.  But, with technology continuing to advance, will we be able to eat meat sustainably in the future?In this webinar, we explored the revolutionary food technology making its way on to the market with Thin Lei Win in conversation with Jim Mellon, Executive Director of Agronomics. This is the second discussion in our new ‘Critical Conversations' series with Mars Wrigley UK bringing together pioneers from different technologies looking to build our net-zero and no-carbon future. This event was recorded as part of a live webinar on 10 July 2023.

Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com. For more information, visit ElysabethAlfano.com. Connect with Elysabeth on Linked in here: https://www.linkedin.com/in/elysabeth-alfano-8b370b7/ For more PBH, visit ElysabethAlfano.com/Plantbased-Business-Hour.

H hears about businessman and author Jim Mellon's first book of childrens' fiction, "Juno's Ark", more from the redoubtable Wendy McDowell and another poem from the Manx Youth Bard.

Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com. For more information, visit ElysabethAlfano.com. Connect with Elysabeth on Linked in here: https://www.linkedin.com/in/elysabeth-alfano-8b370b7/ For more PBH, visit ElysabethAlfano.com/Plantbased-Business-Hour.

The outlook for the UK has improved in recent months, with a technical recession now looking like it will be avoided, according to Bloomberg Economics. In fact, the team sees GDP growth in 2023 of 0.1%, up from -0.4%.  Jim Mellon, chairman of Burnbrae, is predicting an even brighter picture. In this week's In the City, he tells hosts David Merritt and Francine Lacqua to look out for 1 to 2% growth this year, thanks to a more stable government, an influx of migrants and gas prices falling sharply.See omnystudio.com/listener for privacy information.

Graham Rowan, Chairman of Beaufort Private Equity, interviews Jim Mellon ahead of the forthcoming Master Investor Show (this recording was made before the date of the show was changed to the 15th of April 2023 due to rail strikes). For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

Jim Mellon, co-founder of The Longevity Forum interview Peter Diamandis, Founder of the XPRIZE Foundation on breakthroughs for the next decade. There is no greater gift on the planet than adding healthy years to one's life. Our inability to live extraordinarily long is either a software problem or a hardware problem. Breakthroughs in diagnostics will help people understand early signs of ageing so we can catch disease from the beginning. In addition, therapeutics are evolving that may help with long term health.     https://thelongevityforum.com

With global uncertainty has come a renewed interest in precious metals in general, and gold in particular. In this podcast episode, Sarah Lowther discusses the gold outlook with major investor, Jim Mellon. For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

With global uncertainty has come a renewed interest in precious metals in general, and gold in particular. In this podcast episode, Sarah Lowther discusses the gold outlook with major investor, Jim Mellon. For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

Today's episode is a remix of short clips from the previous weeks' episodes on guest's recommendations of must-read books. It serves as a teaser into the wealth of insights, entertaining anecdotes, and valuable tips from the various conversations to give you a flavor of the episode and guest.    If you like what you hear, I invite you to check out the full episodes! Further details you will find below.   Timestamps:  00:00 Introduction  01:00 Dr. Amy Killen - ‘The Giving Tree' by Shel Silverstein 01:42 Sergey Young - ‘The Science and Technology of Growing Young' by Serey Young 06:30 Dr. Dale Bredesen - ‘The Machinery of The Brain' by Dean Wooldridge 07:53 Sakiko Reuterskiold - ‘The Count of Monte Cristo' by Alexandre Dumas, ‘The Perennial Philosophy' by Aldous Huxley, ‘Brave New World' by Aldeous Huxley,  09:44 Dr. Joseph Raffaele - ‘Why We Age' by Steven Austad  11:49 Helen Reavey - ‘Atomic Habits' by James Clear  12:24 Marie Cudennec - ‘The Future We Choose' by Christina Figueres and Tom Rivett-Carnac, ‘The Sacred Cow' by Diana Rodgers and Robb Wolf 13:30 Dr. Mohammed Enayat - ‘Juvenescence: Investing in the Age of Longevity' by Jim Mellon and Al Chalabi,  and ‘The Core' by Aki Hintsa14:47 Dr. Kien Vuu - ‘The Thrive State' by Dr. Kien Vuu 18:31 Outro   Full Episode Titles: #3: Dr. Dale Bredesen On Why Cognitive Decline and Alzheimer's is Now Optional, How to Optimize Cognitive Function at Any Age, Testing, Protocols, the Changing Paradigm to 21st Century Medicine for Longevity, and much more #5: Science-Based Scalp Detoxing with Celebrity Hairstylist Helen Reavey, Co-Founder of Act+Acre, the World's First Sustainable Cold Processed Hair Wellness Brand Focusing on Scalp Health #10: Divine Organic Sweet Chocolate Without Sugar, What Fructose Actually Does to the Body, Aging and Performance, Keto Diets, Intermittent Fasting, Hormones, and Benefits of Organic Stevia with Sustainability-Focused NoMoSu Founder Sakiko Reuterskiöld #11: A Gym Knockout Mike Tyson-Style, an Explosion of New Ageing Technologies, How to Feel Half Your Age with Personalized Medicine, Wearables, Optimizing Hormones with PhysioAge Founder Dr. Joseph Raffaele #12: Transforming Our Planet with High-End Sustainable Furniture, Social Entrepreneurship, Responsible Consumerism, Environmental Action, Zero Hunger and Bespoke Designs with Marie Cudennac, Co-Founder of Goldfinger #14: Biohacking for Optimizing Human Performance, the Personalized Healthcare Revolution, Functional Medicine, and Collective Consciousness with Health Futurist and Physician Dr. Mohammed Enayat, Co-Founder of HUM2N #17: Living to 200 in a 25 Year-Old's Body, Helping 1 Billion People Extend Healthy Lifespan, Wearables, Aging as a Disease, Genetic Engineering, AI, Creativity and Responsibility with Longevity Investor and Innovator Sergey Young #18: The Bioenergetic Model, Treating Chronic Disease, Overcoming Adversity, Transforming Mindsets, Inner Confidence and the Future of Preventative Medicine with Performance and Longevity Doctor Kien Vuu #24: Dr. Amy Killen on Sex, Skin, Orgasms for Increased Lifespan, Regenerative and Preventative Medicine, Futuristic-like Procedures for Transformation, Stem Cells, Favorite Advice, Top Tips for Anti-Aging, Dinner Party Superpowers, and more! If you'd like to check out the full episode, simply go to   longevity-and-lifestyle.com/podcast.   For Podcast Show Notes & Transcript visit: https://longevity-and-lifestyle.com/podcast   Follow Claudia on: Instagram: https://www.instagram.com/longevityandlifestyle/?hl=en Facebook: https://www.facebook.com/longevityandlifestyle/ YouTube: https://www.youtube.com/channel/UCZF-s8jsUejc0TpVqnFE1lQ/featured  LinkedIn: https://www.linkedin.com/in/claudia-von-boeselager/ Twitter: https://twitter.com/LongevityLifest Website: https://longevity-and-lifestyle.com/    Past guests on The Longevity & Lifestyle Podcast include Dr. David Perlmutter, Dr. Amy Killen, Sergey Young, Dr. Dale Bredesen, Dr. Kristen Willeumier, Dr. Louise Newson, Dr. Kien Vuu, Dr. Carolina Reis, Marie Diamond, Nikolina Lauc, Morri Chowaiki, Leslie Kenny, Fiona O'Donnell-McCarthy, Mohamed Massaquoi, Nick Potter, Dr. Pamela Kryskow, Dr. Julia Mirer, Dr. Richard Johnson, Isabella Channing, Dina Burkitbayeva, Raewyn Guerrero, Mario Chamorro, Mariko Bangerter, Harris Khan, Juraj Kocar, Dr. Stephanie Manson Brown, Dr. Mohammed Enayat, Helen Reavey, Elena Letyagina, Dana Frost, Niall Breslin, Dr. Limor Goren and many more!

Jim Mellon co-founder of The Longevity Forum leads a discussion with Kristen Fortney, CEO and founder of BioAge Labs and James Peyer, CEO and founder of Cambrian Biopharma on the future of youth's interest in longevity. Ageing is universal – it happens to everyone compared to other diseases. Kristen and James discuss how organisations are working towards preventing this universal inevitability. From recent breakthroughs to the financial climate for biotech funding, these biotech pioneers open our eyes to the amazing progress in the industry.   https://bioagelabs.com   https://www.cambrianbio.com   https://thelongevityforum.com 

Having just interviewed Jim Mellon on a Food Innovation & Invement Summit panel, I thought it would be a good idea to re-run this interview. Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com.

Having just interviewed Jim Mellon on a Food Innovation & Invement Summit panel, I thought it would be a good idea to re-run this interview. Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com.

The field of longevity has long been considered to be theoretical and one for the future, but that future is here now. The science of ketosis promises lucrative opportunities in a wide range of therapeutic areas, and the global keto market is expected to rise to $15 billion by 2027. Juvenescence has brought together the leading experts in the ketone metabolism research field for a panel discussion on the revolution happening with ketones and the direction the research is leading the key players in this space. We cover how ketones can modulate fundamental aspects of human physiology, including glucose metabolism, brain function and heart health. Juvenescence was founded with a mission to transform what aging means to the world. Science around aging is accelerating at an extraordinary pace so we've set out to further that science through a coalition of the best scientists, physicians and investors creating cutting-edge therapies and products that will empower people to chart their own path forward. Our company represents a modality-agnostic portfolio of therapies developed by seasoned drug developers augmented by machine learning. We have raised over $200MM to date and are organized around two major divisions: JuvRx (Drug Therapies) and JuvLife (NonRx IP-protected and clinically-studied food ingredients and dietary supplements). Get the experts' insights on the latest research and development, hear from our founders, Dr. Greg Bailey and Jim Mellon on the opportunity areas in the market. For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

The field of longevity has long been considered to be theoretical and one for the future, but that future is here now. The science of ketosis promises lucrative opportunities in a wide range of therapeutic areas, and the global keto market is expected to rise to $15 billion by 2027. Juvenescence has brought together the leading experts in the ketone metabolism research field for a panel discussion on the revolution happening with ketones and the direction the research is leading the key players in this space. We cover how ketones can modulate fundamental aspects of human physiology, including glucose metabolism, brain function and heart health. Juvenescence was founded with a mission to transform what aging means to the world. Science around aging is accelerating at an extraordinary pace so we've set out to further that science through a coalition of the best scientists, physicians and investors creating cutting-edge therapies and products that will empower people to chart their own path forward. Our company represents a modality-agnostic portfolio of therapies developed by seasoned drug developers augmented by machine learning. We have raised over $200MM to date and are organized around two major divisions: JuvRx (Drug Therapies) and JuvLife (NonRx IP-protected and clinically-studied food ingredients and dietary supplements). Get the experts' insights on the latest research and development, hear from our founders, Dr. Greg Bailey and Jim Mellon on the opportunity areas in the market.

Entrepreneur and Longevity investor Jim Mellon talks about how the investment world is rapidly turning to longevity and sustainability for returns and as a result our expectations about ageing, performance and also how we can positively help the environment through changes in how we eat whilst also making ourselves healthier.Please make sure you like, subscribe, rate and review The Evolution Lab wherever you get your podcasts. It helps others discover the podcast more easily!The Evolution Lab is a Pod Prod Production. To find out more, go to www.podprod.co.uk

Investor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com.

nvestor and Author of Moo's Law: The Investor's Guide to the New Agrarian Revolution, Jim Mellon, joins me on The Plantbased Business Hour to discuss his vision for the global shifting food supply chain. Tune in to hear this billionaire's predictions and top investment picks! Subscribe! For plant-based media/branding consulting and public speaking, reach out at elysabeth@elysabethalfano.com. For more information, visit ElysabethAlfano.com.

In this episode we talk to Anthony Chow Co-Founder of Agronomics. Agronomics invests in cultivated meat companies in order to disrupt the animal farming industry due to its impact to the environment and animal welfare. Following on from the chat with Jim Mellon, Executive Director of Agronomics we get key insights and updates from Anthony. We discuss what they look for when deciding which cultivated meat companies to invest in and how they tell the difference between real scientific innovation and hype. Additionally they have a keen interest to challenge the traditional leather industry and have invested in a company that creates cell-based leather without the cruelty. https://agronomics.im/ About PLANT CEO More people are choosing to follow plant-based diets or are reducing their meat intake. Exciting new startups are developing alternatives to traditional meat, dairy and seafood products, Whether it be food, fashion or health and beauty there are companies that are trying to change the way we consume products whilst reducing the impact on the planet. Hear from some of the inspirational entrepreneurs that are leading the way forward. https://plantceo.com/

Register to watch panel virtually on 9 Nov: https://thelongevityforum.com/registration-longevity-forum-2021 On this episode, Jim Mellon, co-founder of the Longevity Forum speaks with Henry Dimbleby, co-founder of Leon Foods and the lead on the National Food Strategy Report. The food system dominates the biosphere yet it has been collapsing from our harmful practices.  Without sustainable food, humankind is not sustainable. How can we work together with corporations and governments to ensure our agricultural practices keep us healthy and living longer? https://thelongevityforum.com

My guest Jim Mellon is an accomplished investor, entrepreneur, author and philanthropist. His most recent book called "Moo's Law" focuses on the investment opportunities in the field of cellular agriculture, which is a production of proteins and materials directly from stem cells.  Jim Mellon co-founded Agronomics to invest in a portfolio of leading companies in this sector, as he is its largest investor. In this conversation, we dig into this new area, we talk about the case for change, the challenges and opportunities, some of the people, and some of the nations that are driving and supporting these forward thinking cell-ag companies. What We Cover:  - How Jim developed his interest in biotech, longevity and cellular agriculture - Why industrial agriculture needs to change and what cell-ag offers to the world - The concepts of Moo's Law and griddle parity  - Which different categories of industry cellular agriculture are disrupting and revolutionising - The current state of cell-ag markets and products, and why Middle Eastern countries are faster to adopt this new industry - What challenges are facing the ramp up of cell-ag - The attractive characteristics of cell-ag companies for investors  - When we can expect cell-ag meat and fish to enter the European and US markets on larger scale Key Learnings and Takeaways:  - Moo's law suggests that as scale increases in the manufacture of foods in laboratory conditions, the efficiency will go up and the price will come down - Food-insecure countries such as Middle Eastern countries which import most of their food, will provide a model for implementing cell-ag for larger markets, such as the UK, EU and USA - The challenges facing cell-ag industry are performance of the stem cell lines on massive scale, using animals to continually provide more stem cells, and the execution of startup companies in this field   Links and Resources Mentioned in This Episode:  - Agronomics https://agronomics.im/  - Juvenescence https://www.juvlabs.com/  - ‘Moo's Law: An Investor's Guide to the New Agrarian Revolution' by Jim Mellon https://mooslawbook.com/  - 'Juvenescence: Investing in the Age of Longevity' by Jim Mellon https://www.amazon.com/Juvenescence-Investing-longevity-Mellon-Jim/dp/0993047815/  - 'Cracking the Code: Understand and Profit from the Biotech Revolution That Will Transform Our Lives and Generate Fortunes' by Jim Mellon https://www.amazon.com/Jim-Mellon/dp/1119963184/  - Blue Nalu https://www.bluenalu.com/  - Ivy Farm Technologies https://www.ivy.farm/  - Mohnish Pabrai: Cloning, Learning from Charlie Munger, 100 Baggers on OutsideVoices https://outsidelens.com/mohnish-pabrai-cloning/ - Joel Greenblatt: The Common Sense of Long-Term Investing on OutsideVoices https://outsidelens.com/joel-greenblatt-the-common-sense-of-long-term-investing/ Connect with Mark Bidwell: - LinkedIn https://www.linkedin.com/in/markbidwell/  - Twitter https://twitter.com/markehb

Jim Mellon answers your questions in a live webinar. From the financial crisis, to biotech, and now longevity and clean meat, Jim Mellon is consistently ahead of the game when it comes to anticipating big structural trends - the money trees that can make investors a fortune. For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

Our second monthly Future of Longevity panel discussion featuring: George Church (Harvard Medical School) Nir Barzilai (Albert Einstein College of Medicine) Kristen Fortney (BioAge Labs) Jim Mellon (Juvenescence) Jay Olshansky (University of Illinois at Chicago) Alejandro Ocampo (University of Lausanne)

From the financial crisis, to biotech, and now longevity and clean meat, Jim Mellon is consistently ahead of the game when it comes to anticipating big structural trends - the money trees that can make investors a fortune. For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

The agriculture industry's economic landscape is changing—and fast. Jim Mellon's new book, Moo's Law, helps readers understand the quickly evolving investment landscape in cultivated and plant-based proteins. Recently, he sat down with Sentient Media Founder Mikko Jarvenpaa to unpack the alternative protein market, what investors should be doing, what they shouldn't be doing, and what they have to look forward to.“When consumers are confronted with the choice of meat or seafood that has no hormones, no antibiotics, no toxins, nothing that's bad for you and possibly stuff that's good for you,” says Mellon, “and a very positive environmental and animal impact, why wouldn't they do it, especially if it's cheaper than the conventional stuff?”Mellon is betting that cultivated meat and seafood won't just be popular. He thinks they'll change the industry entirely. “I was skeptical when I first started writing the book that was going to happen,” says Mellon. “But I'm convinced it's going to happen now. I think [the agriculture industry] is going to be an industry that is taken over much faster than any other industry in recent history.”About Sentient MediaAll proceeds from this event go directly into funding Sentient Media.Sentient Media is a nonprofit media organization that produces independent reporting on farmed animal lives and our broken food system.Our mission is to increase public awareness of key issues that matter to all of us: the treatment and well-being of all sentient beings and the health of our planet.We believe exposure is the first step toward behavioral change. That's why we bring together journalists, digital marketing, and tech expertise to reach a diverse audience.In 2020, our animal-related content reached over 1 million readers, with over 25 million first page impressions on Google, 250 articles published on Sentient Media and 72 articles placed in outside media including The Guardian, USA Today, WIRED, NY Daily News, Citizen Truth, The Times, and more.Newsletter: https://sentientmedia.org/newsletter​ Facebook: https://facebook.com/sentientmediaorg​ Twitter: https://twitter.com/sentient_media​ Instagram: https://instagram.com/sentient_media​ LinkedIn: https://www.linkedin.com/company/sent...​

Jim Mellon has written Moo's Law to provide the reader with the first-ever review of the entire alternative protein category, and the associated supply chain of meat, poultry, seafood and allied industries, and also goes a step further with his investment assessment of every leading company in this space. He is joined on this webinar with two of the leading authorities in the industry, Mark Post (Chief Scientific Officer, Mosa Meat) and Lou Cooperhouse (President & CEO of BlueNalu) for what promises to be an enlightening hour for both those familiar with the cellular agriculture sector and those who are new to the New Agrarian Revolution. For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

Bruce Friedrich, Co-founder of The Good Food Institute will be interviewed by Jim Mellon, co-founder of The Longevity Forum and Michael Corcoran, Partner at Hill Dickinson on the future of clean meat in a resilient world. Clean meat is not only better for the environment, but it also decreases dependence on antibiotics and improves food security. From cat food to cellular grown fish, we are creating new, sustainable ways to cultivate meat while avoiding the negative externalities of traditional agriculture. The field of agronomics is experiencing tremendous innovation and growth.  https://thelongevityforum.com

Longevity Week 2020 is taking place virtually on 9-13 November with an array of partner events ranging from UKRI, Zinc VC to Master Investor. The three Longevity Forum founders, Jim Mellon, Andrew Scott and Dafina Grapci-Penney discuss their favourite events coming up and why discussing resilience is so crucial with the pandemic this year. https://thelongevityforum.com

James Faulkner, Jim Mellon and Phil Newman discuss some of the amazing opportunities and challenges presented by the advancement of longevity science with particular reference to how private investors can learn more and get involved. For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

From the financial crisis, to biotech, and now longevity and clean meat, Jim Mellon is consistently ahead of the game when it comes to anticipating big structural trends - the money trees that can make investors a fortune. For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

The Master Investor himself Jim Mellon talks to James Faulkner about his latest investing activities and thoughts on the markets. Topics covered include: Has the stock market rally gone too far too fast? Are gold and precious metals stocks a buy on the dip? Other commodity stocks of interest in an inflationary environment Clean meat and 'Moo's Law' The US election and Brexit For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

It is looking increasingly likely that Coronavirus will continue to affect us all for the short and, potentially, medium term. If that proves to be the case, investors should be prepared for a period of increased market uncertainty and volatility. Join master investor Jim Mellon and Netwealth's CEO Charlotte Ransom as they discuss: How investing during bear markets can be highly rewarding over the long run Strategies to deploy capital during volatile markets Cyclicals vs defensives Mental discipline and investor psychology Charlotte Ransom Charlotte is CEO of Netwealth, a challenger wealth manager. Having started her career at JP Morgan, she spent 20 years at Goldman Sachs, serving as partner for 10 years. Charlotte holds the CISI Private Client Investment Advice and Management qualification, and is one of PAM's 50 Most Influential 2019 and 2020. Jim Mellon Jim is an entrepreneur with flair for identifying emerging global trends, building a worldwide business empire. He is among the top 10% in the “Sunday Times Rich List” and often described as the British Warren Buffett. He predicted the Credit Crunch of 2007-08 in a book entitled “Wake Up! Survive and Prosper in the Coming Economic Turmoil”. Jim followed this with many other best sellers, most recently, “Juvenescence” (2017). His monthly “Mellon on the Markets” column in Master Investor Magazine has gained him cult status among investors. He holds a master's degree in Politics, Philosophy and Economics from Oxford University James Faulkner James drew on his love of investing to pursue a career in financial media at t1ps.com, then part of the Rivington Street Holdings group of companies. James quickly progressed to become Editor-in-Chief of Master Investor and is responsible for all Master Investor content. For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

In this live webinar recording, James Faulkner hosts a lineup of some of the most insightful investment experts on the planet: Jim Mellon, James Ferguson and Victor Hill. The discussion delves into the coronavirus crisis and its implications for markets. For more investment and economics analysis plus inspiration please visit our website masterinvestor.co.uk.

Dafina Grapci-Penney, Jim Mellon and Andrew Scott highlight the collaborative effort of The Longevity Forum and the key takeaways from the day. The social and science narrative on longevity are changing which is very exciting for the future.  

This week's guest is Jim Mellon, billionaire investor, speaker, and co-author of Juvenescence: Investing in the Age of Longevity. We discuss: * His 2005 book that predicted the oncoming storm of the GFC * The coming bear market in tech stocks and why he's short Facebook * The new developments in the treatment of cancer, heart disease, lung disease, and diabetes that could significantly improve survivability * The changes in lifestyle that are already extending our lifespans Medications that could dramatically extend lifespans and healthspans * The winners, losers, and economic effects of longer lives